|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - MyoKardia Inc (MYOK)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-10-02 Sale |
2019-10-04 5:27 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
5,000 | $52.82 | $264,111 | 500,000 (Indirect Direct) |
View |
| 2019-09-23 Sale |
2019-09-24 6:23 pm |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
13,051 | $59.51 | $776,724 | 115,617 (Direct) |
View |
| 2019-09-20 Sale |
2019-09-24 4:05 pm |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
19,700 | $60.09 | $1,183,777 | 85,768 (Direct) |
View |
| 2019-09-19 Sale |
2019-09-20 5:31 pm |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
5,435 | $57.08 | $310,254 | 128,242 (Direct) |
View |
| 2019-09-11 Sale |
2019-09-12 4:16 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
1,000 | $55 | $55,000 | 500,000 (Indirect Direct) |
View |
| 2019-09-03 Sale |
2019-09-05 4:05 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
4,000 | $52.15 | $208,585 | 500,000 (Indirect Direct) |
View |
| 2019-08-09 Sale |
2019-08-12 8:40 pm |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
4,565 | $57 | $260,219 | 133,677 (Direct) |
View |
| 2019-08-08 Sale |
2019-08-09 5:11 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
1,000 | $55.09 | $55,090 | 500,000 (Indirect Direct) |
View |
| 2019-08-02 Sale |
2019-08-05 4:05 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
4,000 | $53.23 | $212,935 | 500,000 (Indirect Direct) |
View |
| 2019-07-22 Sale |
2019-07-23 4:05 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
1,000 | $55 | $55,000 | 500,000 (Indirect Direct) |
View |
| 2019-07-05 Sale |
2019-07-08 5:35 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
4,000 | $49.73 | $198,903 | 500,000 (Indirect Direct) |
View |
| 2018-01-02 Sale(A) |
2019-04-17 8:25 pm |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
5,000 | $42.89 | $214,466 | 71,777 (Direct) |
View |
| 2019-04-05 Sale |
2019-04-09 6:19 pm |
MyoKardia Inc | MYOK | Harris Taylor C. CFO |
1,324 | $53.3 | $70,569 | 11,250 (Direct) |
View |
| 2019-02-13 Sale |
2019-02-15 06:05 am |
MyoKardia Inc | MYOK | Sanofi 10% Owner |
4,168,899 | $37.66 | $157,000,736 | 0 (Indirect) |
View |
| 2019-01-07 Sale |
2019-01-11 8:18 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
2,770 | $44.11 | $122,197 | 500,000 (Indirect Direct) |
View |
| 2019-01-04 Purchase |
2019-01-08 7:12 pm |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
2,500 | $39.86 | $99,647 | 500,000 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-09-23 Exercise |
2019-09-24 6:23 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
12,625 | $11.95 | 115,617 (Direct) |
View |
| 2019-09-23 Exercise |
2019-09-24 6:23 pm |
N/A 2027-01-31 |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
12,625 | $11.95 | 115,617 (Direct) |
View |
| 2019-09-20 Exercise |
2019-09-24 4:05 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
10,000 | $9.08 | 85,768 (Direct) |
View |
| 2019-09-20 Exercise |
2019-09-24 4:05 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
9,700 | $12.25 | 85,768 (Direct) |
View |
| 2019-09-20 Exercise |
2019-09-24 4:05 pm |
N/A 2026-02-01 |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
10,000 | $9.08 | 85,768 (Direct) |
View |
| 2019-09-20 Exercise |
2019-09-24 4:05 pm |
N/A 2027-01-17 |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
9,700 | $12.25 | 85,768 (Direct) |
View |
| 2019-09-19 Exercise |
2019-09-20 5:31 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
5,435 | $11.95 | 128,242 (Direct) |
View |
| 2019-09-19 Exercise |
2019-09-20 5:31 pm |
N/A 2027-01-31 |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
5,435 | $11.95 | 128,242 (Direct) |
View |
| 2019-08-09 Exercise |
2019-08-12 8:40 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
4,565 | $11.95 | 133,677 (Direct) |
View |
| 2019-08-09 Exercise |
2019-08-12 8:40 pm |
N/A 2027-01-31 |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
4,565 | $11.95 | 133,677 (Direct) |
View |
| 2019-07-05 Gift |
2019-07-08 5:35 pm |
N/A N/A |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
39,000 | $0 | 500,000 (Direct) |
View |
| 2019-07-05 Gift |
2019-07-08 5:35 pm |
N/A N/A |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
39,000 | $0 | 500,000 (Indirect) |
View |
| 2019-06-13 Option Award |
2019-06-17 7:01 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | PERRY MARK L Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 7:01 pm |
N/A N/A |
MyoKardia Inc | MYOK | PERRY MARK L Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:59 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | YARNO WENDY L Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:59 pm |
N/A N/A |
MyoKardia Inc | MYOK | YARNO WENDY L Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:59 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | CRANSTON MARY B Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:59 pm |
N/A N/A |
MyoKardia Inc | MYOK | CRANSTON MARY B Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:57 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | Meeker David P Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:57 pm |
N/A N/A |
MyoKardia Inc | MYOK | Meeker David P Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:55 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | AGARWAL SUNIL Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:55 pm |
N/A N/A |
MyoKardia Inc | MYOK | AGARWAL SUNIL Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:54 pm |
N/A 2029-06-12 |
MyoKardia Inc | MYOK | Popovits Kimberly J Director |
6,600 | $47.17 | 6,600 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 6:54 pm |
N/A N/A |
MyoKardia Inc | MYOK | Popovits Kimberly J Director |
2,300 | $0 | 6,600 (Direct) |
View |
| 2019-04-30 Option Award |
2019-06-03 5:48 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June EVP Chief Development Officer |
401 | $40.78 | 4,579 (Direct) |
View |
| 2019-04-30 Option Award |
2019-06-03 5:48 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
313 | $40.78 | 66,068 (Direct) |
View |
| 2019-04-30 Option Award |
2019-06-03 5:48 pm |
N/A N/A |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
503 | $40.78 | 500,000 (Direct) |
View |
| 2018-01-02 Exercise |
2019-04-17 8:25 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
5,000 | $12.25 | 71,777 (Direct) |
View |
| 2018-01-02 Exercise |
2019-04-17 8:25 pm |
N/A 2027-01-17 |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
5,000 | $12.25 | 71,777 (Direct) |
View |
| 2019-04-05 Exercise |
2019-04-09 6:19 pm |
N/A N/A |
MyoKardia Inc | MYOK | Harris Taylor C. CFO |
3,750 | $0 | 11,250 (Direct) |
View |
| 2019-04-05 Exercise |
2019-04-09 6:19 pm |
N/A N/A |
MyoKardia Inc | MYOK | Harris Taylor C. CFO |
3,750 | $0 | 11,250 (Direct) |
View |
| 2019-03-14 Exercise |
2019-03-18 5:32 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June See Remarks |
1,758 | $11.95 | 138,242 (Direct) |
View |
| 2019-03-14 Exercise |
2019-03-18 5:32 pm |
N/A 2027-01-31 |
MyoKardia Inc | MYOK | Lee June See Remarks |
1,758 | $11.95 | 138,242 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:32 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | LADD CYNTHIA J General Counsel |
55,100 | $40.11 | 55,100 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:32 pm |
N/A N/A |
MyoKardia Inc | MYOK | LADD CYNTHIA J General Counsel |
18,800 | $0 | 55,100 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:31 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | Semigran Marc Chief Medical Officer |
24,900 | $40.11 | 24,900 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:31 pm |
N/A N/A |
MyoKardia Inc | MYOK | Semigran Marc Chief Medical Officer |
8,500 | $0 | 24,900 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:28 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | Lee June See Remarks |
65,000 | $40.11 | 65,000 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:28 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June See Remarks |
22,600 | $0 | 65,000 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:27 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | Lambing Joseph See Remarks |
24,900 | $40.11 | 24,900 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:27 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lambing Joseph See Remarks |
8,500 | $0 | 24,900 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:24 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | McDowell Robert Scott Chief Scientific Officer |
57,400 | $40.11 | 57,400 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:24 pm |
N/A N/A |
MyoKardia Inc | MYOK | McDowell Robert Scott Chief Scientific Officer |
19,800 | $0 | 57,400 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:23 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
236,500 | $40.11 | 236,500 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:23 pm |
N/A N/A |
MyoKardia Inc | MYOK | GIANAKAKOS ANASTASIOS CEO |
81,200 | $0 | 236,500 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:21 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | Harris Taylor C. CFO |
49,400 | $40.11 | 49,400 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:21 pm |
N/A N/A |
MyoKardia Inc | MYOK | Harris Taylor C. CFO |
17,000 | $0 | 49,400 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:20 pm |
N/A 2029-02-07 |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
57,400 | $40.11 | 57,400 (Direct) |
View |
| 2019-02-08 Option Award |
2019-02-12 4:20 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
19,800 | $0 | 57,400 (Direct) |
View |
| 2019-02-01 Option Award |
2019-02-05 5:27 pm |
N/A 2029-01-31 |
MyoKardia Inc | MYOK | Fairey William See Remarks |
69,500 | $40.99 | 69,500 (Direct) |
View |
| 2019-02-01 Option Award |
2019-02-05 5:27 pm |
N/A N/A |
MyoKardia Inc | MYOK | Fairey William See Remarks |
32,500 | $0 | 69,500 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-09 9:36 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lee June See Remarks |
1,100 | $44.06 | 2,420 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-09 9:32 pm |
N/A N/A |
MyoKardia Inc | MYOK | Semigran Marc Chief Medical Officer |
517 | $44.26 | 1,110 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-09 9:21 pm |
N/A N/A |
MyoKardia Inc | MYOK | Bauer Jake Chief Business Officer |
570 | $42.98 | 60,755 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-09 9:19 pm |
N/A N/A |
MyoKardia Inc | MYOK | Lambing Joseph See Remarks |
351 | $43.99 | 94,740 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-09 9:15 pm |
N/A N/A |
MyoKardia Inc | MYOK | McDowell Robert Scott Chief Scientific Officer |
767 | $44.15 | 1,158 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 17 Oct 2019 10:28:09 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |